Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Pacira Pharm Inc (PCRX)

Pacira Pharm Inc (PCRX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Pacira Pharm Inc 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 USA

P: 973-254-3560

Description:

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development, commercialization and manufacture of new pharmaceutical products, based on its proprietary DepoFoam drug delivery technology, for use in hospitals and ambulatory surgery centers. Pacira Pharmaceuticals, Inc. is based in New Jersey.

Key Statistics

Overview:

Market Capitalization, $K 1,900,429
Shares Outstanding, K 41,731
Annual Sales, $ 337,280 K
Annual Net Income, $ -470 K
Last Quarter Sales, $ 104,690 K
Last Quarter Net Income, $ -6,090 K
60-Month Beta 1.17
% of Insider Shareholders 5.80%
% of Institutional Shareholders 99.13%
Float, K 39,311
% Float 94.20%

Growth:

1-Year Return -3.68%
3-Year Return 40.56%
5-Year Return -51.79%
5-Year Revenue Growth 294.25%
5-Year Earnings Growth 116.96%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings 0.48 on 11/07/19
Next Earnings Date N/A
Earnings Per Share ttm 0.81
EPS Growth vs. Prev Qtr 13.04%
EPS Growth vs. Prev Year 136.36%
Annual Dividend Rate, $ 0.00
Annual Dividend Yield 0.00%
Dividend Payout Ratio 0.00

PCRX Ratios

Ratio
Price/Earnings ttm 57.01
Price/Earnings forward -225.52
Price/Earnings to Growth 2.07
Return-on-Equity (After Tax) 10.19
Return-on-Assets (Before Tax) 4.54
Profit Margin % -0.14
Net Margin % N/A
Debt/Equity 0.99
Price/Sales 5.71
Price/Cash Flow 48.31
Price/Book 5.55
Book Value/Share 8.31
Interest Coverage -0.98
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar